Gastric cancer (GC) is the fifth most common type of cancer and the third leading cause of
death due to cancer worldwide. The gastric mucosa often undergoes many years of …

Background The combination of pepsinogen, gastrin‐17 and anti‐H. pylori antibodies
serological assays (panel test) is a non‐invasive tool for the diagnosis of atrophic gastritis …

Patients with chronic atrophic gastritis or intestinal metaplasia (IM) are at risk for gastric
adenocarcinoma. This underscores the importance of diagnosis and risk stratification for …

Objective Operative link on gastritis assessment (OLGA) staging for gastritis ranks the risk for
gastric cancer (GC) in progressive stages (0–IV). This prospective study aimed at quantifying …

Chronic atrophic gastritis (CAG) is an underdiagnosed condition characterised by
translational features going beyond the strict field of gastroenterology as it may manifest …

Background Random biopsies are recommended to identify individuals at risk of gastric
adenocarcinoma. Cumulative evidence suggests that narrow-band imaging (NBI) can be …

Introduction: Atrophic gastritis (AG) is a complex syndrome which arises as a consequence
of H. pylori infection or in the context of gastric autoimmunity. It often deserves a benign …

Gastric cancer (GC) is one of the leading causes of cancer related death in the world,
particularly in East Asia. According to the Correa's cancer cascade, non-cardia GC is usually …

Gastric intestinal metaplasia (GIM) is a known premalignant condition of the human stomach
along the pathway to gastric cancer (GC). Histologically, GIM represents the replacement of …

Chronic gastritis (CG) is a persistent inflammation of the gastric mucosa that can cause
uncomfortable symptoms in patients. Traditional Chinese medicine (TCM) has been widely …